1. Velpeau A. Dictionnaire de Medicine, un Repertoire des Sciences Medicales sons le Rapport, Theorique et Pratique. 2nd ed Paris. 1839:91. 2.

Verneuil A. Etudes sur les tumeurs de la peau et quelques maladies des glandes sudoripores. Arch Gen Med. 1854;4:693-705. 3. Schiefferdecker B. Die Hautdrusen des Menschen und der Saugetierre ihre Histologishe und rassenanatomische Bedeutung Sowie die Muscularis Sexualis. Stuttgart. 1922. 4. Brunsting HA. Hidradenitis suppurativa: abscess of the apocrine sweat glands. Arch fur Dermatol und Syph (Berlin). 1939;39:108-20. 5. Pillsbury DM, Shelley WB, Kligman AM. Bacterial infections of the skin. In: Dermatology. Philadelphia: WB Saunders Co; 1956:482-9. 6. Plewig G, Kligman AM. Acne: Morphogenesis and Treatment. Berlin: Springer-Verlag; 1975. 7. Plewig G, Steger M. Acne inversa (alias acne triad, acne tetrad, or hydradenitis suppurativa). In: Marks R, Plewig G, eds. Acne and Related Disorders. London: Martin Dunitz Ltd; 1989:343-57. 8. Yu CC, Cook MG. Hidradenitis suppurativa: a disease of follicular epithelium, rather than apocrine glands.Br J Dermatol. Jun 1990;122(6):763-9. [Medline]. 9. Attanoos RL, Appleton MA, Douglas-Jones AG. The pathogenesis of hidradenitis suppurativa: a closer look at apocrine and apoeccrine glands. Br J Dermatol. Aug 1995;133(2):254-8. [Medline]. 10. Jemec GB, Heidenheim M, Nielsen NH. The prevalence of hidradenitis suppurativa and its potential precursor lesions. J Am Acad Dermatol. Aug 1996;35(2 Pt 1):191-4. [Medline]. 11. Sellheyer K, Krahl D. "Hidradenitis suppurativa" is acne inversa! An appeal to (finally) abandon a misnomer.Int J Dermatol. Jul 2005;44(7):535-40. [Medline]. 12. Jemec GB. What's new in hidradenitis suppurativa?. J Eur Acad Dermatol Venereol. Sep 2000;14(5):340-1.[Medline]. 13. Revuz JE, Canoui-Poitrine F, Wolkenstein P, et al. Prevalence and factors associated with hidradenitis suppurativa: results from two case-control studies. J Am Acad Dermatol. Oct 2008;59(4):596-601. [Medline]. 14. Jemec GB, Heidenheim M, Nielsen NH. Hidradenitis suppurativa--characteristics and consequences. Clin Exp Dermatol. Nov 1996;21(6):419-23. [Medline]. 15. von der Werth JM, Jemec GB. Morbidity in patients with hidradenitis suppurativa. Br J Dermatol. Apr 2001;144(4):809-13. [Medline]. 16. Parks RW, Parks TG. Pathogenesis, clinical features and management of hidradenitis suppurativa. Ann R Coll Surg Engl. Mar 1997;79(2):83-9. [Medline]. [Full Text]. 17. Manolitsas T, Biankin S, Jaworski R, Wain G. Vulval squamous cell carcinoma arising in chronic hidradenitis suppurativa. Gynecol Oncol. Nov 1999;75(2):285-8. [Medline]. 18. Fearfield LA, Staughton RC. Severe vulval apocrine acne successfully treated with prednisolone and isotretinoin. Clin Exp Dermatol. May 1999;24(3):189-92. [Medline].

19. Jemec GB. Hidradenitis suppurativa. J Cutan Med Surg. Jan-Feb 2003;7(1):47-56. [Medline]. 20. Brown TJ, Rosen T, Orengo IF. Hidradenitis suppurativa. South Med J. Dec 1998;91(12):1107-14.[Medline]. 21. Palmer RA, Keefe M. Early-onset hidradenitis suppurativa. Clin Exp Dermatol. Sep 2001;26(6):501-3.[Medline]. 22. Mengesha YM, Holcombe TC, Hansen RC. Prepubertal hidradenitis suppurativa: two case reports and review of the literature. Pediatr Dermatol. Jul-Aug 1999;16(4):292-6. [Medline]. 23. Weber-LaShore A, Huppert JS. Hidradenitis suppurativa in a pre-pubertal female. J Pediatr Adolesc Gynecol. 2009;22:e53. 24. Barth JH, Layton AM, Cunliffe WJ. Endocrine factors in pre- and postmenopausal women with hidradenitis suppurativa. Br J Dermatol. Jun 1996;134(6):1057-9. [Medline]. 25. Misery I, Faure M, Claidy A. Pityriasis rubra pilaris and human immunodeficiency virus infection--type 6 pityriasis rubra pilaris?. Br J Dermatol. Dec 1996;135(6):1008-9. [Medline]. 26. Leybishkis B, Fasseas P, Ryan KF, Roy R. Hidradenitis suppurativa and acne conglobata associated with spondyloarthropathy. Am J Med Sci. Mar 2001;321(3):195-7. [Medline]. 27. von der Werth JM, Jemec GB. Morbidity in patients with hidradenitis suppurativa. Br J Dermatol. Apr 2001;144(4):809-13. [Medline]. 28. Alikhan A, Lynch PJ, Eisen DB. Hidradenitis suppurativa: a comprehensive review. J Am Acad Dermatol. Apr 2009;60(4):539-61; quiz 562-3. [Medline]. 29. Jansen T, Romiti R, Plewig G, Altmeyer P. Disfiguring draining sinus tracts in a female acne patient. Pediatr Dermatol. Mar-Apr 2000;17(2):123-5. [Medline]. 30. Roy MK, Appleton MA, Delicata RJ, Sharma AK, Williams GT, Carey PD. Probable association between hidradenitis suppurativa and Crohn's disease: significance of epithelioid granuloma. Br J Surg. Mar 1997;84(3):375-6. [Medline]. 31. Martnez F, Nos P, Benlloch S, Ponce J. Hidradenitis suppurativa and Crohn's disease: response to treatment with infliximab. Inflamm Bowel Dis. Nov 2001;7(4):323-6. [Medline]. 32. Church JM, Fazio VW, Lavery IC, Oakley JR, Milsom JW. The differential diagnosis and comorbidity of hidradenitis suppurativa and perianal Crohn's disease. Int J Colorectal Dis. Sep 1993;8(3):117-9. [Medline]. 33. Jansen T, Plewig G. What's new in acne inversa (alias hidradenitis suppurativa)?. J Eur Acad Dermatol Venereol. Sep 2000;14(5):342-3. [Medline]. 34. Gonzalez-Lopez A, Velasco E, Pozo T, Del Villar A. HIV-associated pityriasis rubra pilaris responsive to triple antiretroviral therapy. Br J Dermatol. May 1999;140(5):931-4. [Medline]. 35. Kleeman D, Trueb RM, Schmid-Grendelmeier P. [Reticular pigmented anomaly of the flexures. Dowling-Degos disease of the intertrigo type in association with acne inversa]. Hautarzt. Jul 2001;52(7):642-5.[Medline]. 36. Libow LF, Friar DA. Arthropathy associated with cystic acne, hidradenitis suppurativa, and perifolliculitis capitis abscedens et suffodiens: treatment with isotretinoin. Cutis. Aug 1999;64(2):87-90. [Medline].

37. Thein M, Hogarth MB, Acland K. Seronegative arthritis associated with the follicular occlusion triad. Clin Exp Dermatol. 2004;29:545-62. 38. Bhosale P, Barron B, Lamki L. The "SAPHO" syndrome: a case report of a patient with unusual bone scan findings. Clin Nucl Med. Jul 2001;26(7):619-21. [Medline]. 39. Cosman BC, Al-Refaie WB. Mammillary fistula as a manifestation of acne inversa (hidradenitis suppurativa): report of two cases. J Am Coll Surg. Jun 2002;194(6):82933. [Medline]. 40. Ah-Weng A, Langtry JA, Velangi S, Evans CD, Douglas WS. Pyoderma gangrenosum associated with hidradenitis suppurativa. Clin Exp Dermatol. Nov 2005;30(6):66971. [Medline]. 41. Pavlovic M. Oboljenja apokrinih znojnih zlezda. In: Karadaglic D, ed. Dermatologija Beograd: Vojnoizdavacki Zavod. 2000:754-61. 42. Shelley WB, Cahn MM. The pathogenesis of hidradenitis suppurativa in man; experimental and histologic observations. AMA Arch Derm. Dec 1955;72(6):562-5. [Medline]. 43. Lapins J, Jarstrand C, Emtestam L. Coagulase-negative staphylococci are the most common bacteria found in cultures from the deep portions of hidradenitis suppurativa lesions, as obtained by carbon dioxide laser surgery. Br J Dermatol. Jan 1999;140(1):90-5. [Medline]. 44. Mowad CM, McGinley KJ, Foglia A, Leyden JJ. The role of extracellular polysaccharide substance produced by Staphylococcus epidermidis in miliaria. J Am Acad Dermatol. Nov 1995;33(5 Pt 1):729-33. [Medline]. 45. Kurzen H, Kurokawa I, Jemec GB, et al. What causes hidradenitis suppurativa?. Exp Dermatol. May 2008;17(5):455-6; discussion 457-72. [Medline]. 46. Fitzsimmons JS, Guilbert PR, Fitzsimmons EM. Evidence of genetic factors in hidradenitis suppurativa. Br J Dermatol. Jul 1985;113(1):1-8. [Medline]. 47. Montgomery JR, White TW, Martin BL, Turner ML, Holland SM. A novel connexin 26 gene mutation associated with features of the keratitis-ichthyosis-deafness syndrome and the follicular occlusion triad. J Am Acad Dermatol. Sep 2004;51(3):377-82. [Medline]. 48. Gao M, Wang PG, Cui Y, et al. Inversa acne (hidradenitis suppurativa): a case report and identification of the locus at chromosome 1p21.1-1q25.3. J Invest Dermatol. Jun 2006;126(6):1302-6. [Medline]. 49. Lapins J, Olerup O, Emtestam L. No human leukocyte antigen-A, -B or -DR association in Swedish patients with hidradenitis suppurativa. Acta Derm Venereol. Jan-Feb 2001;81(1):2830. [Medline]. 50. Lapins J, Asman B, Gustafsson A, Bergstrom K, Emtestam L. Neutrophil-related host response in hidradenitis suppurativa: a pilot study in patients with inactive disease. Acta Derm Venereol. May 2001;81(2):96-9. [Medline]. 51. Giamarellos-Bourboulis EJ, Antonopoulou A, Petropoulou C, et al. Altered innate and adaptive immune responses in patients with hidradenitis suppurativa. Br J Dermatol. Jan 2007;156(1):51-6. [Medline].

52. Hunger RE, Surovy AM, Hassan AS, Braathen LR, Yawalkar N. Toll-like receptor 2 is highly expressed in lesions of acne inversa and colocalizes with C-type lectin receptor. Br J Dermatol. Apr 2008;158(4):691-7.[Medline]. 53. Champion RH. Disorder of sweat glands. In: Rook A, Wilkinson DS, Ebling FJ, eds. Textbook of Dermatology. 6th ed. Oxford: Blackwell Science; 1998:1985-2002. 54. Edlich RF, Winters KL, Britt LD, Long WB 3rd, Gubler KD, Drake DB. Difficult wounds: an update. J Long Term Eff Med Implants. 2005;15(3):289-302. [Medline]. 55. Wiseman MC. Hidradenitis suppurativa: a review. Dermatol Ther. 2004;17(1):50-4. [Medline]. 56. Lewis F, Messenger AG, Wales JK. Hidradenitis suppurativa as a presenting feature of premature adrenarche. Br J Dermatol. Oct 1993;129(4):447-8. [Medline]. 57. Farrell AM, Randall VA, Vafaee T, Dawber RP. Finasteride as a therapy for hidradenitis suppurativa. Br J Dermatol. Dec 1999;141(6):1138-9. [Medline]. 58. Barth JH. Cutaneous Virilism, Apocrine Glands and Hidradenitis Suppurativa [thesis]. London: University of London; 1992. 59. Jemec GB, Gniadecka M. Sebum excretion in hidradenitis suppurativa. Dermatology. 1997;194(4):325-8.[Medline]. 60. Jansen I, Altmeyer P, Piewig G. Acne inversa (alias hidradenitis suppurativa). J Eur Acad Dermatol Venereol. Nov 2001;15(6):532-40. [Medline]. 61. Wasik F, Barancewicz-Losek M. Hryncewicz-Gwozdz A, Jelen M: Hidradenitis suppurativa complicated by hidradenocarcinoma. Dermatol Klin (Wroclaw). 2001;3 (Suppl 1):64. 62. Jansen T, Plewig G. Acne inversa. Int J Dermatol. Feb 1998;37(2):96-100. [Medline]. 63. Kurzen H, Jung EG, Hartschuh W, Moll I, Franke WW, Moll R. Forms of epithelial differentiation of draining sinus in acne inversa (hidradenitis suppurativa). Br J Dermatol. Aug 1999;141(2):231-9. [Medline]. 64. Kurokawa I, Nishijima S, Kusumoto K, Senzaki H, Shikata N, Tsubura A. Immunohistochemical study of cytokeratins in hidradenitis suppurativa (acne inversa). J Int Med Res. Mar-Apr 2002;30(2):131-6.[Medline]. 65. Kurokawa I, Nishijima S, Suzuki K, et al. Cytokeratin expression in pilonidal sinus. Br J Dermatol. Mar 2002;146(3):409-13. [Medline]. 66. Kurokawa I, Nishimura K, Yamanaka K, Mizutani H, Tsubura A, Revuz J. Cytokeratin expression in squamous cell carcinoma arising from hidradenitis suppurativa (acne inversa). J Cutan Pathol. Sep 2007;34(9):675-8.[Medline]. 67. Jemec GB, Gniadecka M. Ultrasound examination of hair follicles in hidradenitis suppurativa. Arch Dermatol. Aug 1997;133(8):967-70. [Medline]. 68. Slade DE, Powell BW, Mortimer PS. Hidradenitis suppurativa: pathogenesis and management. Br J Plast Surg. Jul 2003;56(5):451-61. [Medline]. 69. Gniadecki R, Jemec GB. Lipid raft-enriched stem cell-like keratinocytes in the epidermis, hair follicles and sinus tracts in hidradenitis suppurativa. Exp Dermatol. Jun 2004;13(6):3613. [Medline].

70. Matusiak L, Bieniek A, Szepietowski JC. Solubile interleukin-2 receptor serum level is a useful marker of hidradenitis suppurativa clinical staging. Biomarkers. 2009;14:432-7. 71. Sartorius K, Lapins J, Emtestam L, Jemec GB. Suggestions form uniform outcome variables when reporting treatment effects in hidradenitis suppurativa. Br J Dermatol. 2003;149:211-3. 72. Bordier-Lamy F, Palot JP, Vitry F, Bernard P, Grange F. [Surgical treatment of hidradenitis suppurativa: a retrospective study of 93 cases]. Ann Dermatol Venereol. May 2008;135(5):373-9. [Medline]. 73. Buimer MG, Wobbes T, Klinkenbijl JH. Hidradenitis suppurativa. Br J Surg. Apr 2009;96(4):350-60.[Medline]. 74. Rompel R, Petres J. Long-term results of wide surgical excision in 106 patients with hidradenitis suppurativa.Dermatol Surg. Jul 2000;26(7):638-43. [Medline]. 75. Bohn J, Svensson H. Surgical treatment of hidradenitis suppurativa. Scand J Plast Reconstr Surg Hand Surg. Sep 2001;35(3):305-9. [Medline]. 76. Aksakal AB, Adisen E. Hidradenitis suppurativa: importance of early treatment; efficient treatment with electrosurgery. Dermatol Surg. Feb 2008;34(2):228-31. [Medline]. 77. Boer J, van Gemert MJ. Long-term results of isotretinoin in the treatment of 68 patients with hidradenitis suppurativa. J Am Acad Dermatol. Jan 1999;40(1):73-6. [Medline]. 78. Tanaka A, Hatoko M, Tada H, Kuwahara M, Mashiba K, Yurugi S. Experience with surgical treatment of hidradenitis suppurativa. Ann Plast Surg. Dec 2001;47(6):636-42. [Medline]. 79. Golcman R, Golcman B, Tamura BM, Nogueira MA, Zoo CM, Germano JA. Subcutaneous fistulectomy in bridging hidradenitis suppurativa. Dermatol Surg. Oct 1999;25(10):7958. [Medline]. 80. Bodzin JH. Laser ablation of complex perianal fistulas preserves continence and is a rectumsparing alternative in Crohn's disease patients. Am Surg. Jul 1998;64(7):627-31; discussion 632. [Medline]. 81. Lapins J, Sartorius K, Emtestam L. Scanner-assisted carbon dioxide laser surgery: a retrospective follow-up study of patients with hidradenitis suppurativa. J Am Acad Dermatol. Aug 2002;47(2):280-5. [Medline]. 82. Madan V, Hindle E, Hussain W, August PJ. Outcomes of treatment of nine cases of recalcitrant severe hidradenitis suppurativa with carbon dioxide laser. Br J Dermatol. Dec 2008;159(6):1309-14. [Medline]. 83. Hynes PJ, Earley MJ, Lawlor D. Split-thickness skin grafts and negative-pressure dressings in the treatment of axillary hidradenitis suppurativa. Br J Plast Surg. Sep 2002;55(6):5079. [Medline]. 84. Rehman N, Kannan RY, Hassan S, Hart NB. Thoracodorsal artery perforator (TAP) type I VY advancement flap in axillary hidradenitis suppurativa. Br J Plast Surg. Jun 2005;58(4):4414. [Medline]. 85. Rhode JM, Burke WM, Cederna PS, Haefner HK. Outcomes of surgical management of stage III vulvar hidradenitis suppurativa. J Reprod Med. Jun 2008;53(6):420-8. [Medline].

86. Frohlich D, Baaske D, Glatzel M. [Radiotherapy of hidradenitis suppurativa--still valid today?]. Strahlenther Onkol. Jun 2000;176(6):286-9. [Medline]. 87. Iwasaki J, Marra DE, Fincher EF, Moy RL. Treatment of hidradenitis suppurativa with a nonablative radiofrequency device. Dermatol Surg. Jan 2008;34(1):114-7. [Medline]. 88. Bong JL, Shalders K, Saihan E. Treatment of persistent painful nodules of hidradenitis suppurativa with cryotherapy. Clin Exp Dermatol. May 2003;28(3):241-4. [Medline]. 89. Buimer MG, Ankersmit MF, Wobbes T, Klinkenbijl JH. Surgical treatment of hidradenitis suppurativa with gentamicin sulfate: a prospective randomized study. Dermatol Surg. Feb 2008;34(2):224-7. [Medline]. 90. Boer J, Nazary M. Long-term results of acitretin therapy for hidradenitis suppurativa. Is acne inversa also a misnomer?. Br J Dermatol. Jan 2011;164(1):170-5. [Medline]. 91. Jamshidi M, Obermeyer RJ, Govindaraj S, Garcia A, Ghani A. Acute pancreatitis secondary to isotretinoin-induced hyperlipidemia. J Okla State Med Assoc. Feb 2002;95(2):7980. [Medline]. 92. Katsanos KH, Christodoulou DK, Tsianos EV. Axillary hidradenitis suppurativa successfully treated with infliximab in a Crohn's disease patient. Am J Gastroenterol. Aug 2002;97(8):2155-6. [Medline]. 93. Lebwohl B, Sapadin AN. Infliximab for the treatment of hidradenitis suppurativa. J Am Acad Dermatol. Nov 2003;49(5 Suppl):S275-6. [Medline]. 94. Rosi YL, Lowe L, Kang S. Treatment of hidradenitis suppurativa with infliximab in a patient with Crohn's disease. J Dermatolog Treat. Feb 2005;16(1):58-61. [Medline]. 95. Trent JT, Kerdel FA. Tumor necrosis factor alpha inhibitors for the treatment of dermatologic diseases.Dermatol Nurs. Apr 2005;17(2):97-107. [Medline]. 96. Sullivan TP, Welsh E, Kerdel FA, Burdick AE, Kirsner RS. Infliximab for hidradenitis suppurativa. Br J Dermatol. Nov 2003;149(5):1046-9. [Medline]. 97. Gupta AK, Skinner AR. A review of the use of infliximab to manage cutaneous dermatoses. J Cutan Med Surg. Mar-Apr 2004;8(2):77-89. [Medline]. 98. Grant A, Gonzalez T, Montgomery MO, Cardenas V, Kerdfel FA. Infliximab therapy for patients with moderate to severe hidradenitis suppurativa: A randomized, double blind, placebo-control crossover trial. J Am Acad Dermatol. 2010;62:205-17. 99. Mekkes JR, Bos JD. Long-term efficacy of a single course of infliximab in hidradenitis suppurativa. Br J Dermatol. Feb 2008;158(2):370-4. [Medline]. 100. Fardet L, Dupuy A, Kerob D, et al. Infliximab for severe hidradenitis suppurativa: transient clinical efficacy in 7 consecutive patients. J Am Acad Dermatol. Apr 2007;56(4):624-8. [Medline]. 101. Usmani N, Clayton TH, Everett S, Goodfield MD. Variable response of hidradenitis suppurativa to infliximab in four patients. Clin Exp Dermatol. Mar 2007;32(2):2045. [Medline].

102. Lee RA, Dommasch E, Treat J, et al. A prospective clinical trial of open-label etanercept for the treatment of hidradenitis suppurativa. J Am Acad Dermatol. Apr 2009;60(4):565-73. [Medline]. 103. Giamarellos-Bourboulis EJ, Pelekanou E, Antonopoulou A, et al. An open-label phase II study of the safety and efficacy of etanercept for the therapy of hidradenitis suppurativa. Br J Dermatol. Mar 2008;158(3):567-72. [Medline]. 104. Zangrilli A, Esposito M, Mio G, Mazzotta A, Chimenti S. Long-term efficacy of etanercept in hidradenitis suppurativa. J Eur Acad Dermatol Venereol. Nov 2008;22(10):1260-2. [Medline]. 105. Yamauchi PS, Mau N. Hidradenitis suppurativa managed with adalimumab. J Drugs Dermatol. Feb 2009;8(2):181-3. [Medline]. 106. Jemec GB. Methotrexate is of limited value in the treatment of hidradenitis suppurativa. Clin Exp Dermatol. Sep 2002;27(6):528-9. [Medline]. 107. Boer J, Jemec GB. Resorcinol peels as a possible self-treatment of painful nodules in hidradenitis suppurativa. Clin Exp Dermatol. 2010;35(1):36-40. 108. Russ E, Castillo M. Lumbosacral epidural abscess due to hidradenitis suppurativa. AJR Am J Roentgenol. 2002;178(3):770-1. 109. Gupta S, Kumar B. Dorsal perforation of prepuce: a common end point of severe ulcerative genital diseases?. Sex Transm Infect. Jun 2000;76(3):210-2. [Medline]. 110. Lapins J, Ye W, Nyren O, Emtestam L. Incidence of cancer among patients with hidradenitis suppurativa.Arch Dermatol. Jun 2001;137(6):730-4. [Medline]. 111. Malaguarnera M, Pontillo T, Pistone G, Succi L. Squamous-cell cancer in Verneuil's disease (hidradenitis suppurativa). Lancet. Nov 23 1996;348(9039):1449. [Medline]. 112. Maclean GM, Coleman DJ. Three fatal cases of squamous cell carcinoma arising in chronic perineal hidradenitis suppurativa. Ann R Coll Surg Engl. Oct 2007;89(7):70912. [Medline]. 113. Crain VA, Gulati S, Bhat S, Milner SM. Marjolin's ulcer in chronic hidradenitis suppurativa. Am Fam Physician. May 1 2005;71(9):1652, 1657. [Medline]. 114. Mandal A, Watson J. Experience with different treatment modules in hidradenitis suppuritiva: a study of 106 cases. Surgeon. Feb 2005;3(1):23-6. [Medline]. 115. Canoui-Poitrine F, Revuz JE, Wolkenstein P, et al. Clinical characteristics of a series of 302 French patients with hidradenitis suppurativa, with an analysis of factors associated with disease severity. J Am Acad Dermatol. 2009;61:51-7. 116. Hofer T, Itin PH. [Acne inversa: a dapsone-sensitive dermatosis]. Hautarzt. Oct 2001;52(10 Pt 2):989-92.[Medline]. 117. Matusiak L, Bieniek A, Szepietowski JC. Hidradenitis suppurativa and associated factors: still unsolved problems. J Am Acad Dermatol. Aug 2009;61(2):362-5. [Medline].